| Bioactivity | Neboglamine (CR-2249, XY-2401) hydrochloride is an orally active NMDA receptor glycine site positive modulator that can be used in schizophrenia research[1]. |
| In Vivo | Neboglamine hydrochloride (s.c. or p.o., 0.3-30 mg/kg) can regulate neuronal activity in brain regions and inhibit PCP-induced hypermobility in rats[1]. Animal Model: |
| Name | Neboglamine hydrochloride |
| CAS | 2759182-59-5 |
| Formula | C13H25ClN2O3 |
| Molar Mass | 292.80 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Riccardo Chiusaroli, et al. Antipsychotic-like effects of the N-methyl-D-aspartate receptor modulator neboglamine: an immunohistochemical and behavioural study in the rat. Pharmacol Res. 2010 May;61(5):430-6. |
Neboglamine hydrochloride
CAS: 2759182-59-5 F: C13H25ClN2O3 W: 292.80
Neboglamine (CR-2249, XY-2401) hydrochloride is an orally active NMDA receptor glycine site positive modulator that can
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.